Table 5.
Univariate and multivariate analysis with Mic group
| OS | BCSS | |||||||
|---|---|---|---|---|---|---|---|---|
| p (log rank) | HR (95% CI) | p (Cox) | p (log rank) | HR (95% CI) | p (Cox) | |||
| Age | < 0.001 | 2.172 (1.881–2.510) | < 0.001 | 0.013 | 2.636 (2.289–3.036) | < 0.001 | ||
| Gender | 0.019 | 0.757 (0.474–1.208) | 0.757 | 0.702 | – | – | ||
| Race | 0.395 | – | – | 0.005 | 0.989 (0.876–1.115) | 0.805 | ||
| Grade | < 0.001 | 1.292 (1.194–1.399) | < 0.001 | < 0.001 | 1.208 (1.118–1.305) | < 0.001 | ||
| Laterality | 0.014 | 0.911 (0.825–1.007) | 0.067 | 0.019 | 0.916 (0.829–1.011) | 0.082 | ||
| Pathology | 0.033 | 0.953 (0.897–1.012) | 0.119 | 0.155 | – | – | ||
| T-stage | < 0.001 | 1.426 (1.321–1.538) | < 0.001 | < 0.001 | 1.322 (1.226–1.424) | < 0.001 | ||
| ALN | 0.027 | 0.891 (0.805–0.986) | 0.026 | 0.794 | – | – | ||
| ER-status | < 0.001 | 0.836 (0.707–0.989) | 0.037 | < 0.001 | 0.921 (0.779–1.088) | 0.333 | ||
| PR-status | < 0.001 | 0.632 (0.562–0.710) | < 0.001 | < 0.001 | 0.690 (0.600–0.793) | < 0.001 | ||
| Tumor extension | < 0.001 | 1.568 (1.296–1.897) | < 0.001 | < 0.001 | 1.649 (1.364–1.995) | < 0.001 | ||
| Chemotherapy | < 0.001 | 0.470 (0.422–0.524) | < 0.001 | 0.554 | – | – | ||
| Radiation | < 0.001 | 0.861 (0.775–0.975) | 0.006 | < 0.001 | 0.776 (0.690–0.849) | < 0.001 | ||
| Surgery | < 0.001 | 1.169 (1.040–1.313) | 0.009 | < 0.001 | 1.124 (1.002–1.260) | 0.046 | ||